Inhibition of PIM by its specific inhibitor AZD1208 [23] failed to affect expression levels of RSK1 and RSK2 also in primary AML cells, although it slightly inhibited RSK NTKD and CTKD. Here, RPS6KA3 is linked to acute myeloid leukemia.